Zou HT, Yang GH, Cai YJ, Chen H, et al. Are high- or low-dose SGLT2 inhibitors associated with cardiovascular and respiratory adverse events? A meta-analysis. J Cardiovasc Pharmacol 2022 Jan 18. pii: 00005344-900000000-98061.
PMID: 35058411